What are the Implications of the Approval of Aduhelm (Aducanumab) to the US Healthcare System?
A conversation with Professor Nicholas Bagley, JD.
Could the FDA’s Approval of a New Drug to Treat Alzheimer’s Disease do More Harm than Good?
A conversation with Dr. Jason Karlawish, MD.